Xiang Wang

Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study

Yuankai Shi, Xingsheng Hu, Shucai Zhang et al. · The Lancet Respiratory Medicine · 2021 · 121 citations

Medicine, Molecular Genetics, Oncology +17

A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004)

Caicun Zhou, Yanping Hu, Ekaterine Arkania et al. · Cancer Cell · 2024 · 60 citations

Medicine, Oncology, Pharmacotherapy +11

miR-375 Inhibits the Proliferation, Migration and Invasion of Esophageal Squamous Cell Carcinoma by Targeting XPR1

Wenbin Wu, Yangmei Zhang, Xiaowu Li et al. · Current Gene Therapy · 2020 · 37 citations

Medicine, Cancer Biology, Oncology +17

MiRNA‐96‐5p impacts the progression of breast cancer through targeting FOXO3

Ziyi Yin, Wenyan Wang, Gengbao Qu et al. · Thoracic Cancer · 2020 · 35 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

SKB264 (TROP2-ADC) for the treatment of patients with advanced NSCLC: Efficacy and safety data from a phase 2 study.

Wen‐Feng Fang, Ying Cheng, Zhendong Chen et al. · Journal of Clinical Oncology · 2023 · 32 citations

Medicine, Oncology, Pharmacology +17